Question 1

What is Intelligence Ventures?

Accepted Answer

Intelligence Ventures is a pre-seed and seed venture capital firm investing in AI-powered healthcare startups in the US and Canada. The thesis is simple: in AI healthcare, the data is the product. We back founders who own or generate proprietary datasets that compound into a durable moat.

Question 2

What stage does Intelligence Ventures invest at?

Accepted Answer

Pre-seed and seed. Initial check sizes are typically $25,000 to $50,000 at post-money valuations under $20M, targeting roughly 1% ownership at entry.

Question 3

What verticals does Intelligence Ventures focus on?

Accepted Answer

Four verticals in AI healthcare: biotech and pharma tools (deepest moats), medical devices (hardware-AI frontier), diagnostics (most underbuilt), and healthcare software (most crowded — we are highly selective and only back teams with proprietary data loops).

Question 4

Where does Intelligence Ventures invest geographically?

Accepted Answer

The United States and Canada. Companies must be operational at the time of investment.

Question 5

What does Intelligence Ventures look for in an AI healthcare startup?

Accepted Answer

Four filters, no exceptions: (1) proprietary data — the team owns or generates data no one else can access; (2) sound science — the underlying biology or technology holds up to expert scrutiny; (3) a multi-disciplinary team of operators, scientists, and builders; (4) a credible path to a category-defining outcome.

Question 6

Does Intelligence Ventures invest in therapeutics?

Accepted Answer

No. We do not invest in therapeutics directly. We invest in the tools, data, devices, and software that make healthcare AI work — not the drugs themselves.

Question 7

How does a founder pitch Intelligence Ventures?

Accepted Answer

Founders can apply directly at intelligencevc.com. We respond fast, give direct feedback, and do not string founders along. Expect a decision in days, not weeks.

Question 8

Who is Doug Nissinoff?

Accepted Answer

Doug Nissinoff is the Founder & General Partner of Intelligence Ventures. He is the author of the AI Healthcare Landscape, read by 18,000+ operators and investors, and is a top-8% graduate of the VC Lab emerging-manager program.

Question 9

Is Intelligence Ventures open to LP commitments?

Accepted Answer

Intelligence Ventures is a 506(c) emerging-manager fund. Accredited LPs and institutional co-investors interested in specialist AI healthcare exposure can contact info@intelligencevc.com.

Question 10

What makes Intelligence Ventures different from other AI healthcare VCs?

Accepted Answer

Three things: scientists in the room on every diligence (PhDs and clinicians pressure-test the technology, not just the pitch); research-first sourcing through a public AI healthcare landscape that pulls founders in; and a small, concentrated fund by design — because the best opportunities at this stage are structurally inaccessible to larger funds.

Most AI healthcare startups will look the same in two years. We find the ones that won't.

Most AI healthcare startups will look
the same in two years. We find
the ones that won't.